LUMATEPERONE

LUMATEPERONE was reported 0 times

LUMATEPERONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MANIC SYMPTOM 24 0.1429
1 COMPULSIVE CHEEK BITING 6 0.1176
2 DRUG METABOLISING ENZYME INCREASED 2 0.0690
3 ABDOMINAL HERNIA INFECTION 2 0.0588
4 CHRONIC CHEEK BITING 2 0.0465
5 POLYMICROGYRIA 2 0.0444
6 PROPULSIVE GAIT 2 0.0444
7 PSEUDOSTROKE 15 0.0436
8 ACUTE OESOPHAGEAL MUCOSAL LESION 2 0.0364
9 HYPERRESPONSIVE TO STIMULI 2 0.0317
10 SEPTO-OPTIC DYSPLASIA 2 0.0303
11 NEGATIVE SYMPTOMS IN SCHIZOPHRENIA 2 0.0299
12 TEMPERATURE REGULATION DISORDER 65 0.0291
13 AUTOSCOPY 14 0.0259
14 INTENTIONAL MISUSE OF DRUG DELIVERY SYSTEM 2 0.0238
15 CHANGE IN SUSTAINED ATTENTION 7 0.0233
16 HYPOMANIA 71 0.0193
17 MANIA 315 0.0191
18 ELECTRIC SHOCK SENSATION 52 0.0186
19 NUCLEATED RED CELLS 2 0.0179
20 SCHIZOAFFECTIVE DISORDER BIPOLAR TYPE 4 0.0174
21 COLD FLASH 2 0.0172
22 CEREBRAL DYSGENESIS 1 0.0167
23 CAFFEINE ALLERGY 1 0.0161
24 PERFORATION BILE DUCT 2 0.0154
25 DISSOCIATIVE AMNESIA 2 0.0154
26 BRIEF RESOLVED UNEXPLAINED EVENT 2 0.0152
27 PERFORMANCE STATUS DECREASED 68 0.0146
28 AKATHISIA 198 0.0145
29 SERUM SEROTONIN DECREASED 2 0.0126
30 TONGUE MOVEMENT DISTURBANCE 10 0.0117
31 SPEECH SOUND DISORDER 2 0.0116
32 SOLILOQUY 10 0.0116
33 SEDATION 292 0.0111
34 ORTHOSTATIC HYPERTENSION 6 0.0103
35 TACHYPHRENIA 34 0.0098
36 TONGUE SPASM 3 0.0096
37 EXPOSURE TO FUNGUS 2 0.0093
38 ASOCIAL BEHAVIOUR 3 0.0093
39 VERY LOW DENSITY LIPOPROTEIN INCREASED 2 0.0090
40 SLEEP PARALYSIS 13 0.0088
41 FLASHBACK 5 0.0087
42 DISSOCIATIVE DISORDER 6 0.0083
43 GRANDIOSITY 3 0.0082
44 TRANCE 3 0.0082
45 PARANASAL SINUS HYPOSECRETION 2 0.0080
46 ANTI-THYROID ANTIBODY INCREASED 1 0.0079
47 TARDIVE DYSKINESIA 217 0.0077
48 HANGOVER 27 0.0077
49 CONVULSIVE THRESHOLD LOWERED 3 0.0076
50 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 5 0.0072
51 DELUSIONAL PERCEPTION 3 0.0072
52 FEELING DRUNK 52 0.0070
53 SELF-DESTRUCTIVE BEHAVIOUR 6 0.0069
54 REGRESSIVE BEHAVIOUR 2 0.0069
55 TRICHOTILLOMANIA 4 0.0068
56 INTRUSIVE THOUGHTS 8 0.0068
57 BLUNTED AFFECT 5 0.0068
58 LACK OF ADMINISTRATION SITE ROTATION 2 0.0066
59 PROGESTERONE DECREASED 2 0.0064
60 COLD-STIMULUS HEADACHE 2 0.0063
61 ENURESIS 25 0.0062
62 DISCONTINUED PRODUCT ADMINISTERED 2 0.0061
63 NON-ALCOHOLIC FATTY LIVER 2 0.0059
64 POST CONCUSSION SYNDROME 2 0.0059
65 PNEUMONITIS ASPIRATION 2 0.0058
66 ATRIAL SEPTAL DEFECT REPAIR 1 0.0058
67 ACTIVATION SYNDROME 2 0.0058
68 BLOOD PROLACTIN DECREASED 1 0.0057
69 SERUM SEROTONIN INCREASED 2 0.0056
70 TOBACCO ABUSE 3 0.0056
71 DRUG-GENETIC INTERACTION 2 0.0056
72 BIPOLAR II DISORDER 2 0.0056
73 TIME PERCEPTION ALTERED 2 0.0055
74 FEEDING TUBE USER 2 0.0055
75 OBSESSIVE-COMPULSIVE SYMPTOM 2 0.0054
76 SLEEP-RELATED EATING DISORDER 5 0.0053
77 REPETITIVE SPEECH 3 0.0053
78 PSYCHOTIC SYMPTOM 11 0.0053
79 FEELING OF BODY TEMPERATURE CHANGE 31 0.0053
80 HALLUCINATION, AUDITORY 84 0.0053
81 CHROMATOPSIA 4 0.0053
82 PHYSICAL EXAMINATION ABNORMAL 2 0.0052
83 VAGINAL DISORDER 5 0.0052
84 OESOPHAGEAL INJURY 2 0.0052
85 HEMIPARAESTHESIA 2 0.0051
86 NEGATIVE THOUGHTS 15 0.0051
87 ADULTERATED PRODUCT 1 0.0050
88 PERSISTENT DEPRESSIVE DISORDER 2 0.0050
89 SPONTANEOUS PENILE ERECTION 3 0.0048
90 LOGORRHOEA 17 0.0048
91 BODY TEMPERATURE FLUCTUATION 10 0.0048
92 FLAT AFFECT 11 0.0047
93 RAPID EYE MOVEMENTS SLEEP ABNORMAL 2 0.0047
94 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 2 0.0047
95 PRESSURE OF SPEECH 3 0.0046
96 SUBSTANCE USE 7 0.0045
97 ALDOLASE INCREASED 1 0.0044
98 PARANOIA 76 0.0044
99 DISTURBANCE IN SEXUAL AROUSAL 4 0.0043
100 PHONOPHOBIA 2 0.0043
101 PREGNANCY TEST FALSE POSITIVE 2 0.0043
102 PSYCHOGENIC SEIZURE 4 0.0043
103 BRUXISM 23 0.0043
104 BREATHING-RELATED SLEEP DISORDER 1 0.0042
105 LABELLED DRUG-DRUG INTERACTION ISSUE 6 0.0041
106 BIPOLAR I DISORDER 9 0.0041
107 BRAIN FOG 64 0.0041
108 EXCESSIVE EYE BLINKING 6 0.0041
109 SCHIZOPHRENIA 49 0.0040
110 PSYCHOTIC DISORDER 117 0.0040
111 PSYCHOTIC BEHAVIOUR 4 0.0039
112 SLOW RESPONSE TO STIMULI 5 0.0039
113 VICTIM OF SEXUAL ABUSE 2 0.0038
114 GRIEF REACTION 2 0.0038
115 DISSOCIATION 29 0.0038
116 EXOMPHALOS 2 0.0037
117 SLOW SPEECH 9 0.0037
118 SOMATIC SYMPTOM DISORDER 4 0.0037
119 FORMICATION 25 0.0036
120 PSYCHIATRIC DECOMPENSATION 7 0.0036
121 METABOLIC SURGERY 4 0.0035
122 CRANIOFACIAL FRACTURE 3 0.0035
123 AVERSION 1 0.0035
124 DISTRACTIBILITY 4 0.0035
125 PROTRUSION TONGUE 2 0.0034
126 LIMB REDUCTION DEFECT 2 0.0034
127 SOMNAMBULISM 22 0.0033
128 MEAN PLATELET VOLUME INCREASED 2 0.0033
129 VIOLENCE-RELATED SYMPTOM 5 0.0032
130 BURNING SENSATION 225 0.0032
131 HYPERSOMNIA 91 0.0032
132 BLADDER INJURY 1 0.0031
133 SEDATION COMPLICATION 8 0.0031
134 NEUROLEPTIC MALIGNANT SYNDROME 37 0.0031
135 TIC 17 0.0031
136 SOCIAL ANXIETY DISORDER 2 0.0030
137 CATATONIA 16 0.0030
138 THEFT 2 0.0030
139 HOMICIDAL IDEATION 12 0.0030
140 BLOOD PRESSURE ORTHOSTATIC DECREASED 1 0.0029
141 EUPHORIC MOOD 30 0.0029
142 DYSKINESIA 118 0.0029
143 PRIAPISM 10 0.0029
144 OPHTHALMIC MIGRAINE 2 0.0029
145 COGWHEEL RIGIDITY 3 0.0029
146 RESTLESS LEGS SYNDROME 52 0.0029
147 EMOTIONAL POVERTY 5 0.0029
148 ANTIDEPRESSANT DRUG LEVEL INCREASED 1 0.0028
149 SCHIZOAFFECTIVE DISORDER 5 0.0028
150 BINGE EATING 3 0.0028
151 OBSESSIVE THOUGHTS 5 0.0028
152 INFANTILE SPASMS 2 0.0028
153 VOMITING PROJECTILE 8 0.0028
154 ORTHOSTATIC HYPOTENSION 48 0.0028
155 PILOERECTION 3 0.0027
156 DYSPHEMIA 12 0.0027
157 BODY DYSMORPHIC DISORDER 1 0.0027
158 SUICIDAL IDEATION 244 0.0027
159 HALO VISION 3 0.0027
160 ANISOCORIA 1 0.0026
161 DYSTONIA 51 0.0026
162 EYE MOVEMENT DISORDER 18 0.0026
163 SELF-INJURIOUS IDEATION 11 0.0026
164 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 2 0.0026
165 ALLERGIC COUGH 2 0.0026
166 RESTLESSNESS 94 0.0026
167 GRIMACING 2 0.0026
168 DEPRESSIVE SYMPTOM 9 0.0026
169 MUSCLE DISCOMFORT 2 0.0025
170 EXTRAPYRAMIDAL DISORDER 62 0.0025
171 DELUSION 38 0.0024
172 IMPAIRED SELF-CARE 5 0.0024
173 DRY MOUTH 193 0.0024
174 HALLUCINATIONS, MIXED 10 0.0024
175 SLEEP DEFICIT 5 0.0024
176 SEIZURE LIKE PHENOMENA 4 0.0024
177 BLOOD HOMOCYSTEINE INCREASED 1 0.0023
178 GENITAL BURNING SENSATION 2 0.0023
179 BIPOLAR DISORDER 25 0.0023
180 ABNORMAL SLEEP-RELATED EVENT 3 0.0023
181 SOMNOLENCE 448 0.0022
182 MUSCLE TWITCHING 51 0.0022
183 ANORGASMIA 6 0.0022
184 SCREAMING 14 0.0022
185 HYPERSEXUALITY 4 0.0022
186 CORNEAL ABRASION 3 0.0022
187 DROOLING 15 0.0022
188 ABULIA 2 0.0022
189 POSTURE ABNORMAL 7 0.0021
190 STEREOTYPY 2 0.0021
191 INTRACRANIAL MASS 2 0.0021
192 BLOOD ALKALINE PHOSPHATASE DECREASED 2 0.0021
193 PRODUCT AFTER TASTE 2 0.0021
194 URINARY HESITATION 5 0.0021
195 COMMUNICATION DISORDER 8 0.0021
196 JUDGEMENT IMPAIRED 3 0.0021
197 FEELING COLD 57 0.0020
198 BRADYPHRENIA 13 0.0020
199 MUCOSAL DRYNESS 4 0.0020
200 SEXUAL DYSFUNCTION 23 0.0020
201 BLOOD PROLACTIN INCREASED 9 0.0019
202 IRRITABILITY 114 0.0019
203 METABOLIC DISORDER 11 0.0019
204 INAPPROPRIATE AFFECT 3 0.0019
205 ANGER 64 0.0019
206 ASPARTATE AMINOTRANSFERASE DECREASED 1 0.0019
207 HYDROCELE 2 0.0019
208 NEUROMYOPATHY 2 0.0019
209 MIDDLE INSOMNIA 35 0.0019
210 DISINHIBITION 3 0.0019
211 UTERINE PROLAPSE 2 0.0018
212 BLOOD INSULIN INCREASED 1 0.0018
213 ESSENTIAL TREMOR 2 0.0018
214 UNEVALUABLE EVENT 135 0.0018
215 SLEEP TALKING 3 0.0018
216 DIZZINESS POSTURAL 17 0.0018
217 MATERNAL EXPOSURE DURING BREAST FEEDING 7 0.0017
218 TONGUE HAEMORRHAGE 2 0.0017
219 MUSCLE TIGHTNESS 27 0.0017
220 PANIC REACTION 12 0.0017
221 SLEEP TERROR 7 0.0017
222 AGITATION 120 0.0016
223 DYSARTHRIA 61 0.0016
224 VICTIM OF CRIME 2 0.0016
225 NIGHTMARE 56 0.0016
226 POST-ACUTE COVID-19 SYNDROME 2 0.0016
227 FEELING HOT 99 0.0016
228 SEROTONIN SYNDROME 31 0.0016
229 FRACTURED COCCYX 2 0.0016
230 APATHY 23 0.0016
231 MIGRAINE 150 0.0016
232 THIRST 28 0.0016
233 INITIAL INSOMNIA 16 0.0016
234 OVARIAN CYST RUPTURED 2 0.0016
235 SKIN WARM 9 0.0015
236 DRUG SCREEN POSITIVE 12 0.0015
237 INCONTINENCE 16 0.0015
238 OESOPHAGEAL HAEMORRHAGE 2 0.0015
239 DIZZINESS 754 0.0015
240 SKIN BURNING SENSATION 108 0.0015
241 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 2 0.0015
242 CRYING 53 0.0015
243 TONGUE BITING 3 0.0015
244 HEAD TITUBATION 2 0.0015
245 THERAPEUTIC PRODUCT EFFECT DECREASED 65 0.0014
246 SUDDEN ONSET OF SLEEP 2 0.0014
247 BLEPHAROSPASM 9 0.0014
248 BLOOD OESTROGEN DECREASED 1 0.0014
249 AUDITORY DISORDER 2 0.0014
250 BORDERLINE PERSONALITY DISORDER 1 0.0014
251 GLUTEN SENSITIVITY 2 0.0014
252 CERVICAL RADICULOPATHY 1 0.0014
253 SPEECH DISORDER DEVELOPMENTAL 4 0.0014
254 CARDIAC SEPTAL DEFECT 1 0.0014
255 ALANINE AMINOTRANSFERASE DECREASED 1 0.0014
256 WITHDRAWAL SYNDROME 58 0.0014
257 GASTRIC BYPASS 3 0.0014
258 BLOOD BILIRUBIN UNCONJUGATED INCREASED 1 0.0014
259 OBSESSIVE-COMPULSIVE DISORDER 11 0.0014
260 AUTONOMIC NERVOUS SYSTEM IMBALANCE 4 0.0014
261 BENIGN NEOPLASM OF THYROID GLAND 1 0.0014
262 TRISMUS 7 0.0014
263 ENERGY INCREASED 8 0.0014
264 AMPHETAMINES POSITIVE 1 0.0013
265 FEAR OF DEATH 3 0.0013
266 TREMOR 221 0.0013
267 PRODUCT STORAGE ISSUE 5 0.0013
268 HALLUCINATION 99 0.0013
269 EYELID DISORDER 3 0.0013
270 DAYDREAMING 2 0.0013
271 PANIC DISORDER 5 0.0013
272 COORDINATION ABNORMAL 18 0.0013
273 THINKING ABNORMAL 24 0.0013
274 FEELING OF DESPAIR 6 0.0013
275 URINARY INCONTINENCE 38 0.0013
276 HALLUCINATION, VISUAL 27 0.0013
277 FUNGAEMIA 2 0.0013
278 PHOTOPSIA 8 0.0013
279 FRUSTRATION TOLERANCE DECREASED 10 0.0012
280 PHARYNGEAL SWELLING 12 0.0012
281 FEELING ABNORMAL 291 0.0012
282 NEAR DEATH EXPERIENCE 4 0.0012
283 FEELING JITTERY 23 0.0012
284 FLUID INTAKE REDUCED 6 0.0012
285 TONGUE ULCERATION 4 0.0012
286 FOOD AVERSION 2 0.0012
287 APTYALISM 1 0.0012
288 ALCOHOLISM 5 0.0012
289 MILIARIA 2 0.0012
290 PANIC ATTACK 42 0.0012
291 POSTMENOPAUSAL HAEMORRHAGE 3 0.0011
292 ALCOHOL WITHDRAWAL SYNDROME 1 0.0011
293 PRODUCT PACKAGING DIFFICULT TO OPEN 3 0.0011
294 TERMINAL INSOMNIA 2 0.0011
295 AGGRESSION 56 0.0011
296 CLUMSINESS 3 0.0011
297 POLYURIA 9 0.0011
298 HICCUPS 9 0.0011
299 ESSENTIAL HYPERTENSION 2 0.0011
300 BONE CONTUSION 1 0.0011
301 HOMICIDE 2 0.0011
302 ANXIETY 308 0.0011
303 HYPERACUSIS 4 0.0011
304 AURA 2 0.0011
305 TEMPERATURE INTOLERANCE 11 0.0011
306 ANTIPSYCHOTIC DRUG LEVEL INCREASED 3 0.0011
307 GUN SHOT WOUND 2 0.0011
308 CEREBRAL PALSY 1 0.0011
309 INSOMNIA 279 0.0010
310 ANTINUCLEAR ANTIBODY INCREASED 1 0.0010
311 MOTION SICKNESS 2 0.0010
312 FINE MOTOR SKILL DYSFUNCTION 3 0.0010
313 CONVERSION DISORDER 2 0.0010
314 PARKINSONISM 10 0.0010
315 PERIPHERAL COLDNESS 14 0.0010
316 GENE MUTATION 2 0.0010
317 MUSCLE RIGIDITY 12 0.0010
318 HYPERPHAGIA 4 0.0010
319 ANTISOCIAL BEHAVIOUR 1 0.0010
320 HEAVY MENSTRUAL BLEEDING 9 0.0010
321 EJACULATION FAILURE 2 0.0010
322 DISTURBANCE IN ATTENTION 53 0.0010
323 MOOD SWINGS 31 0.0010
324 COMPULSIVE SHOPPING 2 0.0010
325 SEIZURE 112 0.0010
326 MOVEMENT DISORDER 31 0.0010
327 SPINA BIFIDA 2 0.0010
328 MAJOR DEPRESSION 7 0.0010
329 ERECTION INCREASED 4 0.0010
330 ATTENTION DEFICIT HYPERACTIVITY DISORDER 4 0.0009
331 PSYCHIATRIC SYMPTOM 7 0.0009
332 EYE CONTUSION 2 0.0009
333 TONGUE DISCOMFORT 4 0.0009
334 HYPOPHAGIA 24 0.0009
335 AFFECT LABILITY 9 0.0009
336 STUPOR 3 0.0009
337 OCULOGYRIC CRISIS 2 0.0009
338 BODY TEMPERATURE INCREASED 19 0.0009
339 TEARFULNESS 4 0.0009
340 POOR QUALITY SLEEP 20 0.0009
341 VULVOVAGINAL DRYNESS 3 0.0009
342 PSYCHOMOTOR HYPERACTIVITY 15 0.0009
343 SALIVARY HYPERSECRETION 9 0.0009
344 PRODUCT PACKAGE ASSOCIATED INJURY 2 0.0009
345 POST-TRAUMATIC STRESS DISORDER 6 0.0009
346 AFFECTIVE DISORDER 7 0.0009
347 PARAESTHESIA 140 0.0009
348 BENIGN NEOPLASM 1 0.0009
349 DRUG EFFECT LESS THAN EXPECTED 13 0.0009
350 THERAPEUTIC PRODUCT EFFECT DELAYED 4 0.0009
351 MICTURITION URGENCY 10 0.0009
352 SENSORY DISTURBANCE 14 0.0009
353 DEPRESSION 198 0.0009
354 ADMINISTRATION SITE PAIN 1 0.0009
355 PRESYNCOPE 21 0.0009
356 DISORIENTATION 34 0.0009
357 MYDRIASIS 11 0.0009
358 DECREASED INTEREST 5 0.0008
359 BALANCE DISORDER 73 0.0008
360 HEADACHE 523 0.0008
361 STARING 2 0.0008
362 SPONDYLITIS 3 0.0008
363 FACIAL PARALYSIS 7 0.0008
364 BLOOD UREA DECREASED 1 0.0008
365 BLADDER DISCOMFORT 1 0.0008
366 IMPULSIVE BEHAVIOUR 3 0.0008
367 PHOTOPHOBIA 15 0.0008
368 BREAST TENDERNESS 6 0.0008
369 VASODILATATION 2 0.0008
370 HEAD DISCOMFORT 14 0.0008
371 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 56 0.0008
372 HYPERTHERMIA 6 0.0008
373 MOTOR DYSFUNCTION 8 0.0008
374 ABNORMAL BEHAVIOUR 31 0.0008
375 EAR DISCOMFORT 8 0.0008
376 GALACTORRHOEA 5 0.0008
377 ANAL INCONTINENCE 7 0.0008
378 NIGHT SWEATS 25 0.0008
379 VERTIGO 47 0.0008
380 ABDOMINAL OPERATION 1 0.0008
381 URINE OUTPUT INCREASED 2 0.0008
382 PERSONALITY DISORDER 2 0.0008
383 SUICIDE ATTEMPT 46 0.0008
384 APPETITE DISORDER 5 0.0008
385 PERSONALITY CHANGE 7 0.0008
386 EXPOSURE VIA BREAST MILK 3 0.0008
387 PROTEIN TOTAL INCREASED 2 0.0008
388 YAWNING 2 0.0007
389 URINARY RETENTION 25 0.0007
390 ANION GAP INCREASED 1 0.0007
391 EMOTIONAL DISORDER 23 0.0007
392 SPEECH DISORDER 39 0.0007
393 INTENTIONAL SELF-INJURY 15 0.0007
394 MENTAL IMPAIRMENT 18 0.0007
395 SKIN DISCOMFORT 2 0.0007
396 SWOLLEN TONGUE 23 0.0007
397 NAUSEA 581 0.0007
398 AGORAPHOBIA 1 0.0007
399 APHASIA 22 0.0007
400 COGNITIVE DISORDER 34 0.0007
401 HEAD INJURY 23 0.0007
402 RESPIRATION ABNORMAL 5 0.0007
403 ABNORMAL DREAMS 20 0.0007
404 DRUG SCREEN FALSE POSITIVE 2 0.0007
405 APPLICATION SITE INFLAMMATION 1 0.0007
406 THYROID FUNCTION TEST ABNORMAL 3 0.0007
407 SUICIDAL BEHAVIOUR 3 0.0007
408 POLLAKIURIA 30 0.0007
409 SENSATION OF FOREIGN BODY 6 0.0007
410 THROAT CANCER 3 0.0007
411 MUSCLE FATIGUE 3 0.0007
412 MUSCULOSKELETAL STIFFNESS 62 0.0007
413 CATAPLEXY 1 0.0007
414 OXYGEN SATURATION ABNORMAL 2 0.0007
415 THROAT TIGHTNESS 19 0.0007
416 NASAL CONGESTION 41 0.0007
417 MOOD ALTERED 19 0.0007
418 MOUTH SWELLING 4 0.0007
419 HYPERTONIC BLADDER 2 0.0007
420 PALPITATIONS 81 0.0007
421 DYSPNOEA AT REST 2 0.0007
422 AMENORRHOEA 12 0.0007
423 NECK INJURY 2 0.0007
424 STRABISMUS 2 0.0007
425 HOT FLUSH 51 0.0007
426 CEREBRAL DISORDER 5 0.0007
427 FEAR 18 0.0007
428 CHILLS 78 0.0007
429 THERAPEUTIC RESPONSE SHORTENED 22 0.0007
430 LOSS OF EMPLOYMENT 2 0.0007
431 TENSION 4 0.0007
432 EAR DISORDER 3 0.0007
433 BLOOD PRESSURE DIASTOLIC INCREASED 3 0.0006
434 VISION BLURRED 88 0.0006
435 PRODUCT ADMINISTRATION INTERRUPTED 5 0.0006
436 GAIT DISTURBANCE 121 0.0006
437 HYPERHIDROSIS 81 0.0006
438 GAIT INABILITY 21 0.0006
439 INCOHERENT 4 0.0006
440 REFUSAL OF TREATMENT BY PATIENT 4 0.0006
441 DRUG INTERACTION 97 0.0006
442 DYSPHAGIA 58 0.0006
443 LETHARGY 35 0.0006
444 DYSGRAPHIA 4 0.0006
445 PRODUCT DOSE OMISSION ISSUE 175 0.0006
446 DYSPHORIA 3 0.0006
447 SYNCOPE 59 0.0006
448 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 6 0.0006
449 REGURGITATION 2 0.0006
450 BLOOD CHLORIDE INCREASED 1 0.0006
451 DEPRESSION SUICIDAL 2 0.0006
452 DIPLOPIA 15 0.0006
453 MEMORY IMPAIRMENT 79 0.0006
454 MALABSORPTION 3 0.0006
455 MENTAL DISORDER 25 0.0006
456 HUNGER 8 0.0006
457 BLOOD LACTIC ACID INCREASED 3 0.0006
458 BLOOD TRIGLYCERIDES INCREASED 10 0.0006
459 NYSTAGMUS 3 0.0006
460 PRODUCT CONTAMINATION 2 0.0006
461 CONFUSIONAL STATE 90 0.0006
462 BEHAVIOUR DISORDER 3 0.0006
463 BLOOD PHOSPHORUS DECREASED 2 0.0005
464 VOMITING 257 0.0005
465 PARADOXICAL DRUG REACTION 2 0.0005
466 BODY TEMPERATURE ABNORMAL 1 0.0005
467 BLOOD CHOLESTEROL DECREASED 1 0.0005
468 INTERMENSTRUAL BLEEDING 3 0.0005
469 THERAPEUTIC RESPONSE UNEXPECTED 24 0.0005
470 BLOOD IRON INCREASED 1 0.0005
471 PROTEIN TOTAL DECREASED 2 0.0005
472 DEPRESSED MOOD 28 0.0005
473 IMPAIRED DRIVING ABILITY 6 0.0005
474 INTENTIONAL DOSE OMISSION 15 0.0005
475 SLEEP DISORDER 37 0.0005
476 INCREASED APPETITE 10 0.0005
477 WEIGHT INCREASED 117 0.0005
478 GINGIVAL DISORDER 2 0.0005
479 OESOPHAGEAL ULCER 2 0.0005
480 SOCIAL AVOIDANT BEHAVIOUR 3 0.0005
481 ATELECTASIS 5 0.0005
482 LIMB DISCOMFORT 16 0.0005
483 ELECTROLYTE IMBALANCE 6 0.0005
484 EXPOSURE DURING PREGNANCY 32 0.0005
485 FAECES HARD 2 0.0005
486 DYSSTASIA 15 0.0005
487 IMPAIRED GASTRIC EMPTYING 7 0.0005
488 DISCOMFORT 31 0.0005
489 BODY TEMPERATURE DECREASED 5 0.0005
490 GLUCOSE TOLERANCE IMPAIRED 3 0.0005
491 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
492 SEASONAL ALLERGY 7 0.0005
493 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 27 0.0005
494 DRY THROAT 5 0.0005
495 GOITRE 2 0.0005
496 THERAPY CESSATION 25 0.0005
497 INFLUENZA LIKE ILLNESS 40 0.0005
498 NASAL DRYNESS 3 0.0005
499 BLOOD SODIUM DECREASED 9 0.0005
500 TENSION HEADACHE 2 0.0005
501 BLOOD TESTOSTERONE INCREASED 1 0.0005
502 OFF LABEL USE 407 0.0005
503 AMYOTROPHIC LATERAL SCLEROSIS 1 0.0005
504 AMNESIA 30 0.0005
505 TOOTH INJURY 2 0.0005
506 PAIN IN JAW 13 0.0005
507 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 22 0.0005
508 COLD SWEAT 8 0.0005
509 FALL 148 0.0004
510 EYE INFECTION 5 0.0004
511 RENAL FUNCTION TEST ABNORMAL 2 0.0004
512 ROSACEA 2 0.0004
513 UMBILICAL HERNIA 2 0.0004
514 GASTROINTESTINAL DISORDER 38 0.0004
515 HEART RATE INCREASED 42 0.0004
516 THERMAL BURN 3 0.0004
517 HYPOAESTHESIA 63 0.0004
518 ILLNESS 43 0.0004
519 PARAESTHESIA ORAL 6 0.0004
520 TONGUE DISORDER 3 0.0004
521 ADVERSE EVENT 38 0.0004
522 NEURALGIA 10 0.0004
523 INTENTIONAL UNDERDOSE 3 0.0004
524 HORMONE LEVEL ABNORMAL 2 0.0004
525 ORAL DISORDER 3 0.0004
526 INCORRECT DOSAGE ADMINISTERED 2 0.0004
527 BLINDNESS TRANSIENT 3 0.0004
528 SENSITIVE SKIN 3 0.0004
529 LIGAMENT SPRAIN 4 0.0004
530 TREATMENT NONCOMPLIANCE 22 0.0004
531 LOSS OF CONSCIOUSNESS 51 0.0004
532 HYPOAESTHESIA ORAL 6 0.0004
533 PRODUCT PHYSICAL ISSUE 8 0.0004
534 GLYCOSYLATED HAEMOGLOBIN INCREASED 10 0.0004
535 HYPOTHERMIA 4 0.0004
536 TOXIC ENCEPHALOPATHY 2 0.0004
537 FEEDING DISORDER 8 0.0004
538 APPENDICITIS PERFORATED 1 0.0004
539 SLUGGISHNESS 4 0.0004
540 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 2 0.0004
541 ABNORMAL UTERINE BLEEDING 1 0.0004
542 BLOOD CHLORIDE DECREASED 1 0.0004
543 MUSCULAR WEAKNESS 44 0.0004
544 HYPOTENSION 77 0.0004
545 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
546 BLOOD PRESSURE DECREASED 25 0.0004
547 ALCOHOL ABUSE 1 0.0004
548 WEIGHT DECREASED 104 0.0004
549 DECREASED ACTIVITY 4 0.0004
550 MUSCLE DISORDER 3 0.0004
551 JAW DISORDER 2 0.0004
552 NONSPECIFIC REACTION 2 0.0004
553 ASTHENOPIA 2 0.0004
554 ABDOMINAL DISCOMFORT 61 0.0004
555 AUTISM SPECTRUM DISORDER 2 0.0004
556 CHOKING SENSATION 2 0.0004
557 PRODUCT PHYSICAL CONSISTENCY ISSUE 2 0.0004
558 FATIGUE 275 0.0004
559 DYSURIA 13 0.0004
560 ERECTILE DYSFUNCTION 9 0.0004
561 NEUROLOGICAL SYMPTOM 2 0.0003
562 BLOOD MAGNESIUM DECREASED 3 0.0003
563 HYPOKINESIA 5 0.0003
564 BLOOD PARATHYROID HORMONE INCREASED 1 0.0003
565 MUSCLE SPASMS 63 0.0003
566 HYPERSENSITIVITY 63 0.0003
567 DIARRHOEA 219 0.0003
568 BRADYKINESIA 2 0.0003
569 ATAXIA 4 0.0003
570 OROPHARYNGEAL DISCOMFORT 3 0.0003
571 LIP DRY 3 0.0003
572 ADRENAL INSUFFICIENCY 4 0.0003
573 MYALGIA 56 0.0003
574 EATING DISORDER 7 0.0003
575 TACHYCARDIA 29 0.0003
576 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 2 0.0003
577 MUSCULOSKELETAL CHEST PAIN 5 0.0003
578 ANKLE FRACTURE 5 0.0003
579 SCOLIOSIS 2 0.0003
580 BLOOD BLISTER 1 0.0003
581 SWELLING OF EYELID 2 0.0003
582 THERAPEUTIC RESPONSE CHANGED 2 0.0003
583 BLADDER PAIN 1 0.0003
584 CHEST PAIN 58 0.0003
585 COMPLETED SUICIDE 26 0.0003
586 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
587 CHOKING 6 0.0003
588 PRODUCT AVAILABILITY ISSUE 7 0.0003
589 NERVOUSNESS 16 0.0003
590 BREAST ENLARGEMENT 1 0.0003
591 THERAPY CHANGE 3 0.0003
592 PRODUCT PREPARATION ISSUE 2 0.0003
593 PRODUCT FORMULATION ISSUE 2 0.0003
594 PHOTOSENSITIVITY REACTION 5 0.0003
595 DYSMENORRHOEA 4 0.0003
596 LIP SWELLING 10 0.0003
597 BLOOD POTASSIUM DECREASED 9 0.0003
598 VISUAL IMPAIRMENT 37 0.0003
599 TRANSIENT ISCHAEMIC ATTACK 10 0.0003
600 SINUS CONGESTION 4 0.0003
601 EYE SWELLING 11 0.0003
602 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
603 PRODUCT LABEL ISSUE 2 0.0003
604 CHEST DISCOMFORT 30 0.0003
605 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
606 HAIR GROWTH ABNORMAL 2 0.0003
607 DELIRIUM 10 0.0003
608 FIBROMYALGIA 7 0.0003
609 EXTRASYSTOLES 2 0.0003
610 PRODUCT ODOUR ABNORMAL 3 0.0003
611 FLUSHING 29 0.0003
612 RASH 124 0.0003
613 DECREASED APPETITE 66 0.0003
614 DUODENAL ULCER 2 0.0003
615 TINNITUS 13 0.0003
616 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
617 JOINT INJURY 6 0.0003
618 APPENDICECTOMY 1 0.0003
619 SUBDURAL HAEMATOMA 4 0.0003
620 PARALYSIS 4 0.0003
621 ADVERSE DRUG REACTION 25 0.0003
622 VISUAL FIELD DEFECT 2 0.0003
623 HYPERTENSION 58 0.0003
624 BLOOD GLUCOSE FLUCTUATION 3 0.0003
625 GASTROINTESTINAL PAIN 3 0.0003
626 TOOTH FRACTURE 3 0.0003
627 ANAPHYLACTIC REACTION 15 0.0003
628 ALCOHOL USE 1 0.0003
629 DRUG INEFFECTIVE 357 0.0003
630 CHROMATURIA 6 0.0003
631 REBOUND EFFECT 3 0.0003
632 FOOT FRACTURE 5 0.0003
633 GASTRIC ULCER 5 0.0003
634 ROAD TRAFFIC ACCIDENT 11 0.0003
635 CHOLECYSTECTOMY 3 0.0003
636 SLEEP APNOEA SYNDROME 5 0.0003
637 INSURANCE ISSUE 4 0.0003
638 MENSTRUATION IRREGULAR 7 0.0003
639 DRY EYE 13 0.0003
640 FOOD ALLERGY 2 0.0003
641 CONCUSSION 2 0.0003
642 ASTHENIA 97 0.0003
643 APNOEA 2 0.0003
644 PELVIC FRACTURE 2 0.0003
645 PERIPHERAL SWELLING 39 0.0003
646 PNEUMOTHORAX 4 0.0003
647 CEREBRAL ATROPHY 1 0.0003
648 URTICARIA 42 0.0003
649 ATRIAL FLUTTER 2 0.0003
650 ARTERIOSPASM CORONARY 1 0.0002
651 NOCTURIA 3 0.0002
652 SUBSTANCE ABUSE 2 0.0002
653 ASPHYXIA 2 0.0002
654 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
655 ABNORMAL FAECES 2 0.0002
656 MENSTRUAL DISORDER 2 0.0002
657 ILEUS 3 0.0002
658 HAEMATEMESIS 6 0.0002
659 BLOOD CHOLESTEROL INCREASED 11 0.0002
660 AORTIC VALVE INCOMPETENCE 1 0.0002
661 RETCHING 5 0.0002
662 CARDIAC OPERATION 2 0.0002
663 ABNORMAL SENSATION IN EYE 1 0.0002
664 NECK PAIN 13 0.0002
665 UNRESPONSIVE TO STIMULI 6 0.0002
666 DEHYDRATION 31 0.0002
667 MUSCLE STRAIN 2 0.0002
668 HYSTERECTOMY 2 0.0002
669 BLOOD PRESSURE INCREASED 35 0.0002
670 SARS-COV-2 TEST POSITIVE 3 0.0002
671 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 2 0.0002
672 RESPIRATORY RATE INCREASED 2 0.0002
673 STEVENS-JOHNSON SYNDROME 5 0.0002
674 FACIAL PAIN 2 0.0002
675 ELECTROCARDIOGRAM QT PROLONGED 8 0.0002
676 EXTRA DOSE ADMINISTERED 9 0.0002
677 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
678 NERVE COMPRESSION 2 0.0002
679 IRON DEFICIENCY ANAEMIA 2 0.0002
680 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
681 MENTAL STATUS CHANGES 6 0.0002
682 ARTHRITIS INFECTIVE 1 0.0002
683 SWELLING FACE 14 0.0002
684 APHONIA 3 0.0002
685 FLANK PAIN 2 0.0002
686 PRODUCT PACKAGING ISSUE 2 0.0002
687 THERAPY INTERRUPTED 15 0.0002
688 MALAISE 91 0.0002
689 PRURITUS 79 0.0002
690 APPLICATION SITE BURN 1 0.0002
691 INTENTIONAL OVERDOSE 13 0.0002
692 SINUS DISORDER 4 0.0002
693 BLOOD PRESSURE ABNORMAL 4 0.0002
694 HYPOTONIA 2 0.0002
695 SPINAL FRACTURE 4 0.0002
696 BRAIN INJURY 2 0.0002
697 HEART RATE DECREASED 7 0.0002
698 EYELID PTOSIS 2 0.0002
699 BLOOD GLUCOSE INCREASED 37 0.0002
700 OROPHARYNGEAL PAIN 18 0.0002
701 CEREBRAL ISCHAEMIA 1 0.0002
702 FLATULENCE 11 0.0002
703 THERAPY PARTIAL RESPONDER 3 0.0002
704 JOINT STIFFNESS 5 0.0002
705 MOUTH ULCERATION 4 0.0002
706 POOR QUALITY PRODUCT ADMINISTERED 2 0.0002
707 ABDOMINAL PAIN UPPER 39 0.0002
708 DYSPNOEA 107 0.0002
709 EAR INFECTION 5 0.0002
710 BREAST PAIN 2 0.0002
711 IMPAIRED WORK ABILITY 4 0.0002
712 ANAL FISSURE 1 0.0002
713 LIVER FUNCTION TEST INCREASED 4 0.0002
714 PAIN OF SKIN 5 0.0002
715 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
716 BACK DISORDER 3 0.0002
717 LIMB INJURY 5 0.0002
718 BACK INJURY 2 0.0002
719 PALLOR 5 0.0002
720 INTENTIONAL PRODUCT MISUSE 16 0.0002
721 ASPIRATION 2 0.0002
722 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
723 DRUG LEVEL INCREASED 3 0.0002
724 DENTAL CARIES 2 0.0002
725 LIVER DISORDER 8 0.0002
726 VIRAL INFECTION 6 0.0002
727 ORAL PAIN 4 0.0002
728 RASH PAPULAR 4 0.0002
729 OCULAR DISCOMFORT 2 0.0002
730 HEART RATE IRREGULAR 4 0.0002
731 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3 0.0002
732 CONTUSION 17 0.0002
733 URINARY TRACT INFECTION 30 0.0002
734 SCAB 2 0.0002
735 EPISTAXIS 13 0.0002
736 DEVICE DEFECTIVE 3 0.0002
737 INTENTIONAL PRODUCT USE ISSUE 15 0.0002
738 SURGERY 10 0.0002
739 WRIST FRACTURE 2 0.0002
740 BLOOD PRESSURE FLUCTUATION 4 0.0002
741 TOOTHACHE 3 0.0002
742 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
743 CONSTIPATION 36 0.0002
744 ENCEPHALOPATHY 4 0.0002
745 BLOOD GLUCOSE ABNORMAL 3 0.0002
746 HEPATIC ENZYME INCREASED 11 0.0002
747 PHARYNGITIS 2 0.0002
748 PYREXIA 55 0.0002
749 ACNE 12 0.0002
750 ABDOMINAL PAIN LOWER 4 0.0002
751 BLOOD URINE PRESENT 3 0.0002
752 MUSCLE ATROPHY 2 0.0002
753 CARDIOVASCULAR DISORDER 4 0.0002
754 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
755 THROAT IRRITATION 7 0.0002
756 ERUCTATION 3 0.0002
757 CARDIAC FLUTTER 1 0.0002
758 EAR PAIN 3 0.0002
759 INJECTION SITE INDURATION 2 0.0002
760 TOXICITY TO VARIOUS AGENTS 26 0.0002
761 HAEMORRHOIDS 3 0.0002
762 ORAL HERPES 3 0.0002
763 SKIN FISSURES 3 0.0002
764 SKIN IRRITATION 7 0.0002
765 ALOPECIA 30 0.0002
766 DYSPEPSIA 15 0.0002
767 BEDRIDDEN 2 0.0002
768 PAIN 93 0.0002
769 EXPIRED PRODUCT ADMINISTERED 5 0.0002
770 SKIN DISORDER 5 0.0001
771 PRODUCT ADMINISTRATION ERROR 3 0.0001
772 PRODUCT TASTE ABNORMAL 2 0.0001
773 BLOOD TESTOSTERONE DECREASED 1 0.0001
774 SKIN LESION 4 0.0001
775 DIVERTICULITIS 4 0.0001
776 DIABETES MELLITUS 11 0.0001
777 DEMENTIA 4 0.0001
778 HYPONATRAEMIA 8 0.0001
779 EYE PAIN 8 0.0001
780 IMPAIRED QUALITY OF LIFE 2 0.0001
781 FAECES DISCOLOURED 3 0.0001
782 PRODUCT DISPENSING ERROR 3 0.0001
783 PRODUCT PRESCRIBING ISSUE 3 0.0001
784 GASTROOESOPHAGEAL REFLUX DISEASE 11 0.0001
785 ANGIOEDEMA 6 0.0001
786 TOOTH DISORDER 3 0.0001
787 GLOSSODYNIA 3 0.0001
788 SNEEZING 3 0.0001
789 PRODUCT USE IN UNAPPROVED INDICATION 33 0.0001
790 INTESTINAL OBSTRUCTION 5 0.0001
791 LACRIMATION INCREASED 4 0.0001
792 BRADYCARDIA 7 0.0001
793 OEDEMA PERIPHERAL 16 0.0001
794 BOWEL MOVEMENT IRREGULARITY 1 0.0001
795 ATRIOVENTRICULAR BLOCK 1 0.0001
796 PAIN IN EXTREMITY 38 0.0001
797 CARDIAC DISORDER 12 0.0001
798 NERVOUS SYSTEM DISORDER 4 0.0001
799 PRODUCT USE COMPLAINT 2 0.0001
800 BLOOD ALBUMIN DECREASED 1 0.0001
801 OBESITY 2 0.0001
802 RASH ERYTHEMATOUS 6 0.0001
803 DRUG WITHDRAWAL SYNDROME 11 0.0001
804 MOBILITY DECREASED 9 0.0001
805 BLOOD GLUCOSE DECREASED 6 0.0001
806 ABDOMINAL DISTENSION 13 0.0001
807 RHINORRHOEA 8 0.0001
808 EYE DISORDER 4 0.0001
809 AGEUSIA 3 0.0001
810 RHABDOMYOLYSIS 5 0.0001
811 DYSPHONIA 7 0.0001
812 CELLULITIS 6 0.0001
813 PERICARDITIS 2 0.0001
814 EYE PRURITUS 4 0.0001
815 FACE OEDEMA 2 0.0001
816 HEMIPARESIS 2 0.0001
817 HYPOACUSIS 5 0.0001
818 CARDIAC MURMUR 1 0.0001
819 STOMATITIS 7 0.0001
820 RESPIRATORY TRACT INFECTION 3 0.0001
821 ASTHMA 13 0.0001
822 SYRINGE ISSUE 2 0.0001
823 ANHEDONIA 3 0.0001
824 BLOOD CALCIUM INCREASED 1 0.0001
825 DERMATITIS ATOPIC 6 0.0001
826 CEREBROVASCULAR ACCIDENT 19 0.0001
827 THERAPY NON-RESPONDER 5 0.0001
828 BLOOD BILIRUBIN INCREASED 3 0.0001
829 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 20 0.0001
830 WHITE BLOOD CELL COUNT DECREASED 12 0.0001
831 HOSPITALISATION 17 0.0001
832 OEDEMA 6 0.0001
833 PELVIC PAIN 2 0.0001
834 RESPIRATORY DISTRESS 3 0.0001
835 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
836 COVID-19 19 0.0001
837 CONJUNCTIVITIS 2 0.0001
838 SINUSITIS 11 0.0001
839 APPENDICITIS 1 0.0001
840 SWELLING 10 0.0001
841 HEPATIC CIRRHOSIS 2 0.0001
842 ABORTION INDUCED 1 0.0001
843 OCULAR HYPERAEMIA 5 0.0001
844 MUSCULOSKELETAL DISORDER 2 0.0001
845 PRODUCTIVE COUGH 5 0.0001
846 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
847 DRUG INTOLERANCE 10 0.0001
848 AUTOIMMUNE DISORDER 1 0.0001
849 WHEEZING 6 0.0001
850 DISABILITY 2 0.0001
851 BLADDER DISORDER 1 0.0001
852 UPPER LIMB FRACTURE 2 0.0001
853 EMOTIONAL DISTRESS 12 0.0001
854 NEUTROPHIL COUNT DECREASED 4 0.0001
855 ERYTHEMA 20 0.0001
856 INFLAMMATION 5 0.0001
857 CONDITION AGGRAVATED 29 0.0001
858 BACK PAIN 22 0.0001
859 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 19 0.0001
860 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
861 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
862 JOINT SWELLING 11 0.0001
863 MELAENA 2 0.0001
864 BLOOD CALCIUM DECREASED 1 0.0001
865 INCORRECT DOSE ADMINISTERED 20 0.0001
866 RASH MACULAR 3 0.0001
867 BLOOD IRON DECREASED 1 0.0001
868 BACTERAEMIA 1 0.0001
869 RENAL IMPAIRMENT 7 0.0001
870 SKIN EXFOLIATION 7 0.0001
871 C-REACTIVE PROTEIN INCREASED 3 0.0001
872 BURSITIS 1 0.0001
873 HYPERGLYCAEMIA 3 0.0001
874 CARDIOMEGALY 1 0.0001
875 INJECTION SITE MASS 3 0.0001
876 ABNORMAL WEIGHT GAIN 1 0.0001
877 APPLICATION SITE IRRITATION 1 0.0001
878 PNEUMONIA ASPIRATION 2 0.0001
879 ARTHRALGIA 33 0.0001
880 COUGH 22 0.0001
881 ANAPHYLACTIC SHOCK 2 0.0001
882 SKIN ULCER 2 0.0001
883 DEAFNESS 2 0.0001
884 ANKYLOSING SPONDYLITIS 1 0.0001
885 ADVERSE REACTION 1 0.0001
886 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
887 ABORTION SPONTANEOUS 3 0.0001
888 BLINDNESS 3 0.0001
889 NEUROPATHY PERIPHERAL 7 0.0001
890 ABDOMINAL PAIN 17 0.0001
891 DEVICE DELIVERY SYSTEM ISSUE 2 0.0001
892 BLISTER 4 0.0001
893 BLOOD TEST ABNORMAL 1 0.0001
894 ANGINA PECTORIS 2 0.0001
895 ACCIDENTAL UNDERDOSE 1 0.0001
896 NEEDLE ISSUE 2 0.0001
897 BONE PAIN 4 0.0001
898 LABORATORY TEST ABNORMAL 2 0.0001
899 BRONCHITIS 5 0.0001
900 DRY SKIN 9 0.0001
901 THERAPEUTIC RESPONSE DECREASED 4 0.0001
902 PLEURAL EFFUSION 4 0.0001
903 SKIN DISCOLOURATION 3 0.0001
904 INJECTION SITE RASH 2 0.0001
905 NASOPHARYNGITIS 12 0.0001
906 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
907 BASAL CELL CARCINOMA 1 0.0001
908 COMA 3 0.0001
909 INFLUENZA 7 0.0001
910 HYPOTHYROIDISM 2 0.0001
911 INFECTION 9 0.0001
912 HYPOGLYCAEMIA 3 0.0001
913 BLOOD POTASSIUM INCREASED 1 0.0001
914 IMPAIRED HEALING 2 0.0001
915 OVERDOSE 13 0.0001
916 NEOPLASM MALIGNANT 4 0.0001
917 TYPE 2 DIABETES MELLITUS 2 0.0001
918 CANDIDA INFECTION 1 0.0001
919 NEUTROPENIA 8 0.0001
920 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
921 ECZEMA 3 0.0001
922 INJURY 4 0.0001
923 PANCREATITIS 3 0.0001
924 CEREBRAL HAEMORRHAGE 2 0.0001
925 RASH PRURITIC 3 0.0001
926 ACCIDENTAL OVERDOSE 2 0.0001
927 DYSGEUSIA 4 0.0001
928 AGRANULOCYTOSIS 1 0.0001
929 HEPATIC FUNCTION ABNORMAL 2 0.0001
930 OXYGEN SATURATION DECREASED 3 0.0001
931 EYE IRRITATION 3 0.0001
932 PRODUCT SUBSTITUTION ISSUE 3 0.0001
933 ACUTE RESPIRATORY FAILURE 1 0.0001
934 PRODUCT QUALITY ISSUE 7 0.0001
935 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
936 ARTHRITIS 4 0.0001
937 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
938 ILL-DEFINED DISORDER 3 0.0000
939 DEVICE BREAKAGE 2 0.0000
940 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
941 PRODUCT USE ISSUE 9 0.0000
942 CARDIO-RESPIRATORY ARREST 2 0.0000
943 DEEP VEIN THROMBOSIS 3 0.0000
944 DEVICE LEAKAGE 2 0.0000
945 VAGINAL HAEMORRHAGE 2 0.0000
946 BLOOD CREATININE INCREASED 3 0.0000
947 INJECTION SITE PRURITUS 3 0.0000
948 APPLICATION SITE PRURITUS 1 0.0000
949 NEPHROLITHIASIS 2 0.0000
950 DRUG DEPENDENCE 7 0.0000
951 HYPOKALAEMIA 2 0.0000
952 RENAL DISORDER 2 0.0000
953 DISEASE RECURRENCE 2 0.0000
954 UNDERDOSE 3 0.0000
955 ATRIAL FIBRILLATION 4 0.0000
956 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
957 CHRONIC KIDNEY DISEASE 3 0.0000
958 FLUID RETENTION 2 0.0000
959 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
960 APPLICATION SITE ERYTHEMA 1 0.0000
961 INJECTION SITE BRUISING 3 0.0000
962 PLATELET COUNT DECREASED 4 0.0000
963 CARDIAC FAILURE 3 0.0000
964 CARDIAC ARREST 3 0.0000
965 TREATMENT FAILURE 3 0.0000
966 DRUG ABUSE 3 0.0000
967 ARTHROPATHY 2 0.0000
968 HERPES ZOSTER 2 0.0000
969 PRODUCT STORAGE ERROR 3 0.0000
970 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
971 DEVICE ISSUE 3 0.0000
972 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
973 BREAST CANCER 3 0.0000
974 PNEUMONIA 10 0.0000
975 DEATH 26 0.0000
976 RENAL FAILURE 4 0.0000
977 INJECTION SITE PAIN 9 0.0000
978 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
979 HAEMORRHAGE 3 0.0000
980 SEPSIS 3 0.0000
981 RHEUMATOID ARTHRITIS 3 0.0000
982 ANAEMIA 5 0.0000
983 INJECTION SITE SWELLING 2 0.0000
984 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
985 CARDIAC FAILURE CONGESTIVE 2 0.0000
986 INJECTION SITE ERYTHEMA 3 0.0000
987 NO ADVERSE EVENT 4 0.0000
988 ARRHYTHMIA 1 0.0000
989 PULMONARY EMBOLISM 2 0.0000
990 CATARACT 1 0.0000
991 PSORIASIS 2 0.0000
992 ACUTE KIDNEY INJURY 2 0.0000
993 MYOCARDIAL INFARCTION 2 0.0000